Cresci, Barbara

Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials

Monami, M., Nreu, B., Scatena, A., Cresci, B., Andreozzi, F., Sesti, G., & Mannucci, E. (2017) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 243

Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): Which is better?

Moltrer, M., Pala, L., Cosentino, C., Mannucci, E., Rotella, C. M., & Cresci, B. (2022) · Endocrine

Body Composition Measurement TechniquesObesity, Physical Activity, Diet

Cited by 68

Glucagon‐like peptide 1 ( GLP1 ) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials

Silverii, G. A., Pala, L., Cresci, B., & Mannucci, E. (2025) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDrug-Induced Ocular Toxicity

Cited by 49

Metabolic surgery for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials

Cresci, B., Cosentino, C., Monami, M., & Mannucci, E. (2020) · Diabetes, Obesity and Metabolism

Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques

Cited by 46

Effectiveness of intermittent fasting for weight loss in individuals with obesity: A meta-analysis of randomized controlled trials

Silverii, G. A., Cresci, B., Benvenuti, F., Santagiuliana, F., Rotella, F., & Mannucci, E. (2023) · Nutrition, Metabolism and Cardiovascular Diseases

Dietary Effects on HealthDiet and metabolism studies

Cited by 34